PubRank

Gabriele Capurso

Author PubWeight™ 35.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway. J Clin Oncol 2009 2.94
2 Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer 2005 2.24
3 Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence. Eur J Nucl Med Mol Imaging 2013 2.06
4 Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology 2005 1.61
5 Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression. J Clin Oncol 2011 1.42
6 Celiac disease and CFTR mutations in patients with chronic asymptomatic pancreatic hyperenzymemia. Am J Gastroenterol 2013 1.13
7 Consensus guidelines on severe acute pancreatitis. Dig Liver Dis 2015 1.12
8 Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate. Neuroendocrinology 2011 1.08
9 Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. Gastrointest Endosc 2012 1.05
10 Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells. Endocr Relat Cancer 2007 1.03
11 Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis 2010 1.02
12 Risk factors for disease progression in advanced jejunoileal neuroendocrine tumors. Neuroendocrinology 2011 0.96
13 Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Dig Liver Dis 2012 0.95
14 Expression of the proto-oncogene c-KIT in normal and tumor tissues from colorectal carcinoma patients. Int J Colorectal Dis 2004 0.94
15 Gastric neuroendocrine tumors. Neuroendocrinology 2004 0.89
16 Simultaneous intraductal papillary neoplasms of the bile duct and pancreas treated with chemoradiotherapy. World J Gastrointest Oncol 2012 0.88
17 Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry. Dig Liver Dis 2010 0.88
18 Repeated transabdominal ultrasonography is a simple and accurate strategy to diagnose a biliary etiology of acute pancreatitis. Pancreas 2014 0.87
19 Endocrine tumours of the stomach. Best Pract Res Clin Gastroenterol 2005 0.87
20 ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. Oncol Rep 2013 0.86
21 Diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis. Neuroendocrinology 2015 0.86
22 Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome. Pancreas 2014 0.85
23 Src kinase activity coordinates cell adhesion and spreading with activation of mammalian target of rapamycin in pancreatic endocrine tumour cells. Endocr Relat Cancer 2011 0.85
24 Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations. Cancer Epidemiol Biomarkers Prev 2012 0.81
25 Nasogastric or nasointestinal feeding in severe acute pancreatitis. World J Gastroenterol 2010 0.81
26 Small intestinal bacterial overgrowth in patients with chronic pancreatitis. J Clin Gastroenterol 2014 0.79
27 Outcomes of intraductal papillary mucinous neoplasm with "Sendai-positive" criteria for resection undergoing non-operative management. Dig Liver Dis 2013 0.79
28 Probiotics and severe acute pancreatitis. Addendum. J Clin Gastroenterol 2008 0.76
29 Of bacteria, acid, and blood. Gastroenterology 2005 0.75
30 The role of SRC family kinases in neuroendocrine tumors. Gastroenterology 2012 0.75
31 Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study. Cancer 2008 0.75
32 Is entirely conservative management a correct strategy for hemodynamically stable patient with a grade IV blunt pancreatic injury? World J Surg 2011 0.75
33 Re: Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J Natl Cancer Inst 2004 0.75
34 A Case of Pancreatic Small Cell Neuroendocrine Carcinoma Associated With SIADH. Pancreas 2016 0.75
35 Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid. Dig Liver Dis 2009 0.75
36 Risk and Protective Factors for Small Intestine Neuroendocrine Tumors: A Prospective Case-Control Study. Neuroendocrinology 2015 0.75
37 Phenotype expression in a case of adult cystic fibrosis caused by an extremely rare compound heterozygous genotype (2183AA>G/2789+5G>A). Pancreas 2009 0.75
38 The Use of Complementary and Alternative Medicine is Frequent in Patients With Pancreatic Disorders. J Clin Gastroenterol 2016 0.75